undamentalytics Newsletter
Sign in

Steris income statement

In fiscal 2026, Steris reported revenue of $5.94bn, up 8.7% on the year before, operating income of $1.10bn (a 18.6% margin) and net income of $782m, or $7.93 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Revenue2,6132,6202,7823,0313,1084,2234,5365,1395,4605,9366,038
Cost of revenue1,5871,5271,6071,7111,7642,3402,5562,9213,0573,3093,355
Gross profit1,0261,0931,1751,3201,3431,8831,9812,2182,4032,6272,683
Research and development59616366668798104108113115
Selling, general and administrative6826326707177311,3181,0911,2521,3341,4081,424
Operating income2264004115375484787918368671,1021,142
Interest expense455145403789108144866161
Income before tax1853553694995183676807037961,0471,089
Income tax7463649112182124150185262281
Net income110291304408397244107378615782805
Diluted EPS$1.28$3.39$3.55$4.76$4.63$2.48$1.07$3.81$6.20$7.93$8.18
Diluted shares (average)86m86m85m86m86m98m100m99m99m99m98m
EBITDA4145786377347681,0311,3441,4011,3431,5881,633

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: RMD vs STEEW vs STEBLCO vs STE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Steris's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Steris.